In vitro evaluation of ramoplanin (A16686 or MDL62198): A new depsipeptide complex for potential topical use
- 30 June 1989
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 12 (3), 279-282
- https://doi.org/10.1016/0732-8893(89)90029-1
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Mechanism of mupirocin transport into sensitive and resistant bacteriaAntimicrobial Agents and Chemotherapy, 1989
- Ramoplanin (A-16686), a new glycolipodepsipeptide antibiotic. III. Structure elucidation.The Journal of Antibiotics, 1989
- In vitro evaluation of Ramoplanin (MDL 62198, A 16686)European Journal of Clinical Microbiology & Infectious Diseases, 1988
- Transferable mupirocin-resistanceJournal of Antimicrobial Chemotherapy, 1988
- Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreakJournal of Antimicrobial Chemotherapy, 1988
- Elimination of nasal carriage of Staphylococcus aureus with mupirocin (‘pseudomonic acid’)—a controlled trialJournal of Antimicrobial Chemotherapy, 1986
- A-16686, a new antibiotic from Actinoplanes I. Fermentation, isolation and preliminary physico-chemical characteristics.The Journal of Antibiotics, 1984
- Interaction of pseudomonic acid A with Escherichia coli B isoleucyl-tRNA synthetaseBiochemical Journal, 1980
- Topical Antibiotic Ointments for Staphylococcal Nasal Carriers: Survey of Current Practices and Comparison of Bacitracin and Vancomycin OintmentsInfection Control, 1980
- Pseudomonic Acid: an Antibiotic produced by Pseudomonas fluorescensNature, 1971